Corticotropin-releasing factor receptor type 2 (CRFR2) is highly expressed in skeletal muscle (SM) tissue where it is suggested to inhibit interactions between insulin signaling pathway components affecting whole-body glucose homeostasis. However, little is known about factors regulating SM CRFR2 expression. Here, we demonstrate the exclusive expression of CRFR2, and not CRFR1, in mature SM tissue using RT-PCR and ribonuclease protection assays and report a differential expression of CRF receptors during C2C12 myogenic differentiation. Whereas C2C12 myoblasts exclusively express CRFR1, the C2C12 myotubes solely express CRFR2. Using cAMP luciferase assays and calcium mobilization measurements, we further demonstrate the functionality of these differentially expressed receptors. Using luciferase reporter assays we show a differential activation of CRFR promoters during myogenic differentiation. Transfections with different fragments of the 5Ј-flanking region of the mCRFR2␤ gene fused to a luciferase reporter gene show a promoterdependent expression of the reporter gene and reveal the importance of the myocyte enhancer factor 2 consensus sequence located at the 3Ј-proximal region of CRFR2␤ promoter. Furthermore, we demonstrate that CRFR2 gene transcription in the mature mouse is stimulated by both high-fat diet and chronic variable stress conditions. Performing a whole-genome expression microarray analysis of SM tissues obtained from CRFR2-null mice or wild-type littermates revealed a robust reduction in retinol-binding protein 4 expression levels, an adipokine whose serum levels are elevated in insulin-resistant states. In correlation with the SM CRFR2␤ levels, the SM retinolbinding protein 4 levels were also elevated in mice subjected to high-fat diet and chronic variable stress conditions. The current findings further position the SM CRFR2 pathways as a relevant physiological system that may affect the known reciprocal relationship between psychological and physiological challenges and the metabolic syndrome. (Molecular Endocrinology 25: 157-169, 2011)
Corticotropin-releasing factor receptor type 2 (CRFR2) is highly expressed in skeletal muscle (SM) tissue where it is suggested to inhibit interactions between insulin signaling pathway components affecting whole-body glucose homeostasis. However, little is known about factors regulating SM CRFR2 expression. Here, we demonstrate the exclusive expression of CRFR2, and not CRFR1, in mature SM tissue using RT-PCR and ribonuclease protection assays and report a differential expression of CRF receptors during C2C12 myogenic differentiation. Whereas C2C12 myoblasts exclusively express CRFR1, the C2C12 myotubes solely express CRFR2. Using cAMP luciferase assays and calcium mobilization measurements, we further demonstrate the functionality of these differentially expressed receptors. Using luciferase reporter assays we show a differential activation of CRFR promoters during myogenic differentiation. Transfections with different fragments of the 5Ј-flanking region of the mCRFR2␤ gene fused to a luciferase reporter gene show a promoterdependent expression of the reporter gene and reveal the importance of the myocyte enhancer factor 2 consensus sequence located at the 3Ј-proximal region of CRFR2␤ promoter. Furthermore, we demonstrate that CRFR2 gene transcription in the mature mouse is stimulated by both high-fat diet and chronic variable stress conditions. Performing a whole-genome expression microarray analysis of SM tissues obtained from CRFR2-null mice or wild-type littermates revealed a robust reduction in retinol-binding protein 4 expression levels, an adipokine whose serum levels are elevated in insulin-resistant states. In correlation with the SM CRFR2␤ levels, the SM retinolbinding protein 4 levels were also elevated in mice subjected to high-fat diet and chronic variable stress conditions. The current findings further position the SM CRFR2 pathways as a relevant physiological system that may affect the known reciprocal relationship between psychological and physiological challenges and the metabolic syndrome. A bdominal obesity and insulin resistance have each been proposed as the primary factors underlying metabolic syndrome (1, 2) . Skeletal muscle (SM) comprises the largest insulin-sensitive tissue in humans, and thus, insulin resistance in this organ impacts whole-body glucose homeostasis (3) . Insulin resistance in SM was proposed to promote atherogenic dyslipidemia by decreasing muscle glycogen synthesis and elevating hepatic de novo lipid synthesis and very-low-density lipoprotein production (2) .
The corticotropin-releasing factor (CRF)/urocortin (Ucn) family of peptides and receptors is involved in the maintenance and adaptive responses necessary for energy homeostasis (4 -11) . The CRF/Ucn family of neuropeptides signals through the activation of two G protein-coupled receptors, CRF receptor type 1 (CRFR1) (12) (13) (14) and CRF receptor type 2, CRFR2 (15) (16) (17) (18) . Mouse CRFR2 has three apparent splice variants, which results in two putative receptor proteins of 411 and 431 amino acids (CRFR2␣ and CRFR2␤, respectively) and in a 422-amino acid insertion-variant (iv) with dominant-negative activity. In rodents, CRFR2␣ is predominantly expressed in the brain (19) . The CRFR2␤ splice variant is expressed primarily in the SM, the heart, the brain choroid plexus, the gastrointestinal tract, and the skin (17, 20, 21) whereas ivCRFR2␤ is exclusively expressed in the heart (22) .
In SM tissue, CRFR2␤ was suggested to be involved in different cellular processes. SM CRFR2␤ activation was suggested to impede glucose metabolism. CRFR2-null mice have enhanced glucose tolerance, increased insulin sensitivity and are protected from high-fat diet-induced insulin resistance (6) . Ucn2, which is highly expressed in SM tissue (23) and most likely serves as the endogenous ligand for SM CRFR2␤, inhibits the interactions between insulin-signaling pathway components and insulin-induced glucose uptake in cultured SM cells, and in C2C12 myotubes (8) . The Ucn2-null mice exhibit increased insulin sensitivity and are protected from fat-induced insulin resistance (8) . In addition, CRFR2␤ activation was demonstrated to increase SM mass (24) , reduce SM mass loss in atrophying SM due to denervation or casting, and to increase nonatrophying SM mass (25) .
Given the importance of CRFR2 in regulating the central stress response and its beneficial effect on cardiovascular function (26) , the regulation of its hypothalamic and heart expression has been extensively studied (Refs. 27-31 and Refs. 22 and 32-35, respectively). However, little is known regarding factors regulating SM CRFR2␤ expression. Here, we demonstrate the differential expression of CRFR1 and CRFR2 mRNA during C2C12 myogenic differentiation. The functional signaling of those receptors was determined, and promoter analysis studies demonstrated the importance of muscle-specific transcription factors putative binding sites. Additionally, we show the in vivo regulation of SM CRFR2␤ mRNA by chronic physiological or psychological stressors and its association with insulin-resistant states.
Results

Differential expression of CRFR1 and CRFR2 during myogenic differentiation
To verify expression of SM CRFRs, total RNA prepared from SM and brain tissues was reverse transcribed to generate cDNAs. The cDNA products were used as templates for specific semiquantitative RT-PCR demonstrating selective CRFR2 expression in SM tissue whereas the brain cDNA served as a positive control for CRFR1 and CRFR2 expression (Fig. 1A) . The selective expression of CRFR2, and not CRFR1, in SM tissue was further verified using ribonuclease (RNase) protection assay (Fig.  1B) . The multinucleated SM fibers are formed in successive distinct steps involving different types of myoblasts (36) . For in vitro investigation of the molecular basis of SM cell differentiation, C2C12 cells, mouse-derived myoblasts that can be propagated as undifferentiated mononuclear cells in serum, serve as a useful experimental model. On serum withdrawal, muscle-specific genes are expressed leading to the formation of differentiated multinucleated myotubes (37, 38) . To study the CRFR2 expression profile during myogenic differentiation, RNA extracted from C2C12 myoblasts at different time points during myogenic differentiation was reverse transcribed and used as a template for semiquantitative RT-PCR. The myogenic determination factors MyoD and myogenin, as well as the negative regulator of myogenesis, Id2 (39) , were used to monitor the differentiation process. Unexpectedly, C2C12 myoblasts were found to exclusively express CRFR1 whereas C2C12 myotubes were found to exclusively express CRFR2 (Fig. 1C) . The time-dependent differential expression of the two-receptor forms can be observed during the differentiation process (Fig. 1, C and D). CRFR2 shows expression kinetics similar to MyoD and myogenin expression profiles whereas CRFR1 expression mirrors the expression profile Id2 (Fig. 1, C and D) .
C2C12 cells were further used for demonstrating CRFR1-and CRFR2-selective activation in nondifferentiated (myoblasts) or differentiated (myotubes) state. Receptor functionality was demonstrated by measuring the activation of the cAMP and calcium pathways using CRF or Ucn2/3, which are specific ligands for CRFR1 and CRFR2, respectively (40 -42) . Nondifferentiated C2C12 cells were transfected with a luciferase reporter containing a fragment of the EVX1 gene that contains a cAMP-responsive element (CRE) site. Luciferase activity was used as a measure of receptor activation and was determined after 4 h of treatment with vehicle, and various doses of CRF, or Ucn3 in nondifferentiated, or 48-h differentiated, C2C12 cells. The CRE-luciferase reporter gene was differentially activated in the myoblasts and myotubes after stimulation with CRF or Ucn3, respectively ( Fig. 2A) . In myoblasts, CRF signaling induced CRE-luciferase activity, which was blocked by the CRFR1-specific antagonist Antalarmin (Ant), whereas in the myotubes, Ucn3 signaling induced CRE-luciferase activity that was blocked by the CRFR2-specific antagonist Astressin 2B (Ast 2B).
Additionally, calcium mobilization kinetics were measured in nondifferentiated (myoblasts) or differentiated (myotubes) C2C12 cells by CRF or Ucn2 (Fig. 2B) . Acti-vation of calcium flux was differentially activated in the myoblasts and myotubes after stimulation with CRF. CRF strongly activated calcium flux in myoblasts, but not in myotubes, (Fig. 2B, a and b) . Ucn2 activated calcium flux to a lesser extent in myoblasts, probably due to its low affinity for CRFR1, but did not activate calcium flux in myotubes (Fig. 2B, c and d) . To further explore this phenomenon, the calcium mobilization kinetic studies were duplicated in Chinese hamster ovary (CHO) cells stably expressing CRFR1 or CRFR2 treated with CRF or Ucn2, respectively (Fig. 2C) . Only CRF activation of CHO cells expressing CRFR1, but not Ucn2 activation of CHO cells expressing CRFR2, promoted calcium mobilization. Demonstrating that CRFR1, but not CRFR2, activation will promote calcium mobilization supports the finding of differential expression of the CRFRs during myogenic differentiation.
Differential activation of mCRFR1 and mCRFR2␤ promoters during C2C12 myoblast differentiation
To explore the molecular mechanisms mediating the differential regulation of CRFR1 and CRFR2 during myogenic differentiation, and to examine whether the differential expression is regulated at the promoter level, we , and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (both panels) antisense probes. Brain and pituitary gland served as positive controls for CRFR2 and CRFR1 gene expression, respectively. C, Representative image of electrophoretic analysis of the semiquantitative RT-PCR products of mCRFR1, mCRFR2, muscle differentiation markers, MyoD, myogenin, and Id2 and the ribosomal protein S16 in C2C12 myoblasts cultured in differentiation media (DM). RNA extracted from C2C12 myoblasts cultured in DM (containing 2% horse serum) for 0 -6 d were reverse transcribed to generate cDNA, which were used as templates to the PCR using specific primers for mCRFR1, mCRFR2, MyoD, myogenin, Id2, and the ribosomal protein S16 that served as an internal control. RNA extracted from mouse SM and brain served as positive controls. PCR without RT enzyme (ϪR.T) or without cDNA (ϪcDNA) served as negative controls. D, The bands were quantified, and the normalized values (relative to the control S16 expression) are presented as fold increase. Three independent experiments were conducted and showed similar kinetic of gene expression.
isolated the 5Ј-flanking region of both genes. Subcloning mCRFR1 or mCRFR2␤ 5Ј-flanking sequences upstream to a luciferase gene allowed us to study their activity during the myogenic differentiation (Fig. 3 ). C2C12 cells were transfected with the reporter plasmid DNA, and the luciferase activity over 3 d of myogenic differentiation was determined. Interestingly, myoblast differentiation was accompanied by a significant and rapid inhibition of the mCRFR1 promoter, and time-dependent and robust activation of the mCRFR2␤ promoter (Fig. 3, A and B, respectively). These sequential changes parallel the decrease and the increase in mRNA level of CRFR1 and CRFR2␤, respectively (Fig. 3) , and confirm that mCRFR2␤ expression during differentiation is regulated at the transcriptional level.
To further study the involvement of putative musclespecific transcription factors in the activation of the CRFR2␤ 5Ј-flanking region, the 5Ј-flanking region of FIG. 2. CRFR1 and CRFR2 signaling pathways are differentially activated during the myogenic differentiation. A, Activation of CRE-luciferase reporter by CRF and Ucn3 peptides in C2C12 myoblasts or myotubes, respectively. C2C12 myoblasts were transfected with CRE-luciferase, and luciferase activity was measured after treatment (4 h) with vehicle or 1 pM, 0.1 nM, 10 nM, and 1 M CRF or Ucn3 in nondifferentiated C2C12 cells (black bars) or 48 h differentiated C2C12 cells (white bars). Assays were normalized to cotransfected ␤-gal activity. The mean SEM of three independent experiments is presented as relative activity. The activation of CRE-luciferase in myoblasts by CRF, or in myotubes by Ucn3, was blocked by the CRFR1-specific antagonist (Ant) or CRFR2-specific antagonist Ast 2B, respectively [*, P Ͻ 0.05 vs. vehicle treatment; **, P Ͻ 0.05 vs. CRF (10 nM) or Ucn3 (10 nM) treatment]. B. Calcium mobilization in nondifferentiated (myoblasts) or differentiated (myotubes) C2C12 cells by CRF and Ucn2. Nondifferentiated C2C12 cells (a and c) and differentiated C2C12 (b and d) were treated with CRF (a and b) or Ucn2 (c and d), respectively, and the calcium mobilization kinetic was measured using FlexStation (Molecular Devices Corp.). Bar graphs represent the maximum values. Interestingly, CRFR1 but not CRFR2 activation promotes calcium mobilization. Activation of calcium flux was differentially activated in the myoblasts and myotubes after stimulation with CRF. * P Ͻ 0.05 vs. control buffer. C, CHO cells stably expressing the CRFR1 (a) or CRFR2 (b) were treated with CRF or Ucn2, respectively, and the calcium mobilization kinetic was measured using FlexStation. Bar graphs represent the maximum values. *, P Ͻ 0.05 vs. control buffer. ND, Not determined; Con., control.
CRFR2␤ (Ϫ2495 to ϩ23) was analyzed for SM transcription factor consensus sequences using the TESS program (Transcription Element Search System) (Fig. 4A) . Six fragments of the 5Ј-flanking region, with different lengths and numbers of putative muscle-specific transcription factors consensus sequences, were subcloned into a luciferase pGL3 basic vector and used for transfecting C2C12 cells (Fig. 4, B and C) . The luciferase activity of each fragment during myogenic differentiation was studied. No basal differences were detected between the different fragments. When differentiation medium (DM) was introduced, the promoter activity increased in a time-dependant manner. The differences between the promoter fragments could be detected as early as 24 h in DM, where the full isolated 5Ј-flanking region was strongly activated and its activity was significantly higher compared with the truncated fragments, regardless of their length (Fig. 4C) . After 96 h in DM, all truncated fragments were robustly activated. However, their activity was significantly lower compared with the full 5Ј-flanking region (Fig. 4C) . Although the activity level of the truncated fragments varied, there was no significant difference between them. Interestingly, even the shortest fragment, consisting of 168 bp, was strongly activated, indicating the importance of the proximal site in mediating CRFR2␤ transcription (Fig. 4C) .
Given the strong potency of the short 5Ј-flanking fragment (Ϫ146 to ϩ23), we examined the importance of the putative myocyte enhancer factor (MEF)2 consensus sequence (located Ϫ91 to Ϫ82) for this activation. This MEF2 consensus sequence in the minimal 5Ј-flanking region was mutated and subcloned into pGL3 basic vector.
The MEF2 consensus sequence is YTWWAAATAR, where Y stands for T or C, W stands for A or T, and R stands for A or G (43) . The mutation included C to A and A to C substitutions (CtatAaataa to AtatCaataa) (Fig. 5A) . The mutated sequence is not recognized as MEF2 consensus sequence using the TESS analysis. The WT or mutated fragment were transfected into C2C12 cells, and luciferase activity during myogenic differentiation was measured (Fig. 5B) . The mutated fragment was not able to induce transcription as demonstrated by a constant low activation of the luciferase gene throughout the differentiation process, indicating the significance of this MEF2 site for CRFR2␤ expression during myogenic differentiation.
Regulation of SM CRFR2␤ expression by stress and its correlation to retinol-binding protein 4 (RBP4) expression level
Given the high expression level of CRFR2␤ and its suggested role in modulating insulin sensitivity and glucose uptake, we further studied its regulation in the mature mouse after exposure to chronic stressors. High-fat diet (HFD) and chronic-variable stress (CVS) paradigms were chosen because they represent prolonged physiological and psychological stressors, respectively. SM RNA obtained from mice maintained for 15 wk on HFD or from mice subjected to CVS protocol, and the respective controls, was reverse transcribed, and CRFR2␤ expression levels were determined using real-time PCR. Interestingly, both stressors triggered a significant elevation in CRFR2␤ expression level. HFD induced a 2.3-fold increase (Fig. 6A ) whereas CVS induced a 2.0-fold increase (Fig. 6B) in CRFR2␤ expression level. The expression of Ucn2, the local ligand for SM CRFR2␤, did not change significantly under these conditions (data not shown).
CRFR2 signaling was previously demonstrated to inhibit insulin signaling in SM (8) . To further understand the molecular mechanisms mediating the effect of Ucn2/ CRFR2 signaling on insulin sensitivity in SM, we compared the gene expression profile of SM obtained from both CRFR2 knockout (KO) and WT littermates using gene expression microarray. The microarray analysis demonstrated a significant reduction of 43.5% in the expression level of RBP4. RBP4 is an adipokine whose serum levels are increased in insulin-resistant subjects, and its administration leads to impaired insulin signaling in muscle (44) . To confirm our microarray data, SM was collected from CRFR2-null mice and from their WT littermates, and SM cDNA was used for measuring RBP4 expression level by real-time PCR. The real-time PCR results were in agreement with the microarray findings and showed a significant reduction of 52% in RBP4 expression level (Fig.  7A) . Several genes that were found to be up-or down-regulated in the microarray analysis are listed in Supplemental Table 1 (published on The Endocrine Society's Journals Online web site at http://mend.endojournals.org). These changes were not further verified using additional quantitative methods. Because CRFR2-KO mice are a developmental KO model and therefore may represent developmental compensatory changes, we further examined RBP4 muscle expression level in conditions that up-regulate CRFR2␤ expression, namely HFD and CVS, and found a positive correlation between RBP4 and CRFR2␤ expression. SM RBP4   FIG. 4 . Sequence-, fragmentation-, and differentiation-induced activation of CRFR2␤ 5Ј-flanking region. A, Genomic sequence of mCRFR2␤ 5Ј-flanking region. 5Ј-Untranslated region is shown in italic letters. The six primers used for promoter fragmentation are underlined, and putative sites for muscle-specific transcription factors, recognized using TESS (Transcription Element Search System), are indicated. B, Electrophoretic analysis of pGL3-basic vectors containing truncated mCRFR2␤ 5Ј-flanking region. C, Activity of CRFR2␤ fragmented promoter during myogenic differentiation. C2C12 cells were transfected with the reporter plasmid preceded by the different 5Ј-flanking region fragments. Luciferase activity during the myogenic differentiation in 2% horse serum containing DM was determined. The relative luciferase activity was corrected to ␤-gal activity (results are shown as fold increase over the basal activity of each fragment, shown as mean Ϯ SEM). AS, Antisense.*, P Ͻ 0.05; **, P Ͻ 0.001 vs. the full fragment.
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expression level was significantly elevated in mice subjected to both HFD and CVS manipulations (Fig. 7 , B and C).
Discussion
SM tissue has been demonstrated to express high levels of CRFR2 transcript (20) , which was shown to be associated with controlling glucose transport into the SM. In the present study we demonstrated, using specific mCRFR2 RNase protection assays, RT-PCR, and DNA sequencing, that adult SM tissue expresses CRFR2␤, but not the CRFR1, transcripts. Previous reports showed CRFR2␤ expression in SM to be localized in neural structures, blood vessels, myotendinous junctions, and endomysial/ perimysial spaces, but not in myocytes (45) . Here, we showed that C2C12 myoblasts exclusively express CRFR1, whereas the C2C12 myotubes exclusively express CRFR2␤. In the myoblast state, serum induces the expression of Id proteins, transcription factors that sequester E12 and E47 into complexes unable to bind DNA (39) . Upon serum removal, MyoD family proteins, MyoD, Mrf4, and myogenin, are activated to promote the expression of muscle-specific genes with Mef2 family of transcription factors, which play an important role in this context (46) . This sequential expression pattern is also demonstrated in the CRFR expression kinetics, where CRFR1 expression mirrors the expression profile of Id2, and CRFR2␤ expression kinetics parallels the MyoD and myogenin expression profile. Additional examples of differential expression of CRFRs were reported in other types of muscle tissues. In human nonpregnant myometrium the CRFR1␣ and CRFR1␤-receptor subtypes were found, whereas at term R2␣ and C variant CRFR subtypes were expressed as well (47) . Moreover, we recently reported differential regulation of mCRFR2␤ by stress in heart myocardium. The mRNA levels of mCRFR2␤ were down-regulated in hearts of mice that underwent CVS whereas the mRNA levels of a new splice variant of CRFR2␤, iv-mCRFR2␤, were up-regulated (22) . Lipopolysaccharide was also shown to differentially regulate CRFR2␤ expression in the heart and SM. Systemic injection of lipopolysaccharide up-regulated SM CRFR2 mRNA levels and markedly down-regulated its mRNA heart levels (48).
The pharmacological properties of CRFR1 and CRFR2 activation by different ligands of the CRF peptide family are well established. CRF has relatively lower affinity for CRFR2 compared with its affinity for CRFR1, Ucn1 has equal affinities for both receptors, and Ucn2 and Ucn3 appear to be selective for CRFR2 (40, 42, 49) . Both CRFRs belong to the B1 subfamily of seven-transmembrane-domain receptors that signal by coupling to G proteins (50) . CRFR1 and CRFR2 signaling primarily stimulates the adenylyl cyclase/cAMP pathway via coupling and activation of G␣ s proteins and protein kinase A activation (13, 18, 51) . In addition, CRFR1 is coupled to activation of plasma membrane calcium channels and CRF signaling and was shown to generate changes in corticotrope cytosolic free calcium concentration (52) . The increase in Ca 2ϩ influx involves voltage-gated channels, namely L-and P-type channels (53) . That CRFR1 coupling to activation of plasma membrane calcium channels depends on cell type (54) was demonstrated in melanocytes (55) . We assessed the differential expression of CRFR signaling in assays based on these similarities and differences. CRF and Ucn3 activated CREluciferase reporter gene in myoblasts or myotubes, respectively. The use of selective antagonists and the subsequent activation of the cAMP pathway further emphasized the ligand specificity and functionality of the CRFR subtypes. Furthermore, the ability of CRF to induce calcium mobilization selectively in myoblasts provides an additional level of support to the absence of CRFR1 in differentiated myotubes.
Transient transfection of C2C12 myoblasts with constructs containing the 5Ј-flanking region of the mCRFR1 or mCRFR2␤ genes fused to a luciferase reporter showed differential promoter activity during myogenic differentiation. The CRFR1 promoter activity was negatively regulated, whereas CRFR2␤ promoter activity was positively regulated, during differentiation. This differential regulation is due to the varying responsiveness of the promoters to myogenic transcription factors. Computeraided sequence analysis revealed the presence of putative muscle-specific transcription factor consensus sequences in the mCRFR2␤ 5Ј-flanking region. Different fragments of the 5Ј-flanking region were cloned into a luciferase vector to identify the crucial area needed for CRFR2␤ transcription. A robust activation of all the fragmented regions was observed revealing the importance of the 3Ј-proximal region. The importance of this region was verified by mutating the MEF2 consensus sequence. The mutated fragment was incapable of transcription, as demonstrated by blunted luciferase activity. This short but powerful minimal 5Ј-flanking region may be further used as a minimal promoter for muscle-specific expression of target genes.
Understanding the regulation of SM CRFR2␤ may provide further insight into the physiological functions of this receptor. Mice lacking either CRFR2 or Ucn2 demonstrate enhanced glucose tolerance, increased insulin sensitivity, and protection from high fat diet-induced insulin resistance (6, 8) . In Ucn2 KO mice, systemic Ucn2 administration before glucose tolerance test or insulin tolerance test impaired glucose clearance and reduced insulin sensitivity, respectively (8) , showing that this phenotype is mediated by peripheral CRFR2. Both obesity and high stress, hallmarks of a modern lifestyle, are correlated with insulin resistance (56, 57). We showed that both a physiological stressor (chronic consumption of a HFD) and a psychological stressor (CVS) share the same consequence of elevated SM CRFR2␤ expression level. Consequently, the increased SM CRFR2␤ expression may contribute to the reduced insulin sensitivity, which characterizes these conditions. Elucidation of this phenomenon is essential for better management of the metabolic consequences that coincide with both HFD and chronic psychological stress. Interestingly, a similar CVS protocol mediated a reduction in CRFR2␤ mRNA levels in the hearts of mice (22); however, these tissue-specific differences might be attributed to the up-regulation of the dominant-negative iv-mCRFR2␤ isoform.
A positive correlation between leptin serum levels and CRFR2␣ mRNA levels in the ventromedial hypothalamus has been shown (30) . Because leptin is produced in proportion to fat stores (58) , and full-length leptin receptor is expressed by SM (59), it is intriguing to hypothesize that the increased CRFR2␤ expression under HFD is regulated by leptin. However, the association with leptin does not explain the increased CRFR2␤ expression in mice subjected to CVS, because CVS was demonstrated to reduce serum leptin levels (60) . Both HFD consumption and chronic stress lead to elevated glucocorticoids (60 -62) , which may regulate CRFR2␤ expression under these conditions. HFD and CVS may be considered representatives of modern lifestyle characteristics, which include high stress load and increased intake of high-fat foods. The indication that mice lacking Ucn2 exhibited increased insulin sensitivity and better glucose tolerance (8) implies that Ucn2 is endogenously secreted under hypoglycemic and hyperglycemic states. Glucose serves as the primary fuel molecule in the fight or flight response and is crucial for the organism's survival (4, 63) . Therefore, the inhibitory effect of SM CRFR2␤ on insulin signaling may function to regulate the stress-induced elevation in blood glucose levels and to allow availability of glucose to other tissues. Whereas this function is beneficial under normal conditions, it may be maladaptive under chronic stress conditions, under which SM CRFR2␤ expression is elevated and consequently insulin sensitivity is reduced.
Whole-genome microarray expression data comparing the expression profile of SM obtained from CRFR2 KO or WT littermates showed a robust reduction in RBP4 expression, which was further confirmed by real-time PCR. RBP4 is mainly expressed in liver and adipose tissue (64) . RBP4 serum levels are increased in insulin-resistant mice and in humans with type 2 diabetes (65), and weight loss in morbidly obese patients reduces RBP4 serum level (66). Adipose-specific glucose transporter 4 KO mice demonstrated elevated serum RBP4 levels and secondary insulin resistance in the muscle and the liver (65), a metabolic phenotype that mirrors the observed phenotype of the CRFR2 and Ucn2 KO mice.
RBP4 and CRFR2 signaling disrupt components of SM insulin signaling that play a role in the control of glucose transporter 4 translocation. RBP4 reduces both phosphoinositide3-kinase activity and insulin-stimulated tyrosine phosphorylation of insulin receptor substrate-1 at tyrosine residue 612, a docking site for the p85 subunit of phosphoinositide3-kinase (65), whereas Ucn2 signaling inhibits insulin-induced Akt phosphorylation and reduces ERK1/2 phosphorylation (8) . It was demonstrated that RBP expressed ectopically in mice muscle can elevate serum RBP levels (65) . Here, we demonstrate that HFD and CVS conditions mediate an increase both in SM CRFR2␤ and RBP4 expression levels. This dual increased expression may synergistically act in an autocrine fashion to inhibit insulin signaling and magnify metabolic complications.
The current findings further position the SM-CRFR2 pathways as a relevant physiological system that may affect the known reciprocal relationship between psychological and physiological challenges and the metabolic syndrome. A better understanding of SM CRFR2␤ pathway, its physiological roles, and its regulation may provide benefits in related pathological conditions, such as obesity and type 2 diabetes.
Materials and Methods
Animals
Mice were housed and handled in a pathogen-free temperaturecontrolled (22 C Ϯ1) mouse facility on a 12-h light, 12-h dark cycle (lights on from 1900 h-0700 h), with food and water given ad libitum, according to institutional guidelines. Adult C57BL/6 male mice were used in all experiments. CRFR2-null (129ϫC57Bl/6 mixed background) mice were used for microarray and real-time PCR studies. All experimental protocols were approved by the Institutional Animal Care and Use Committee of The Weizmann Institute of Science.
Cell lines
C2C12 myoblasts were grown to 50% confluence in DMEM (Invitrogen Life Technologies, Carlsbad, CA), containing 10% FBS supplemented with 100 g/ml of penicillin/streptomycin (Invitrogen Life Technologies) (normal growth medium). For differentiation, C2C12 were grown to 90% confluency and washed with serum-free medium, and their medium was replaced with DMEM containing 2% horse serum. CHO cells were grown in normal growth medium as previously described (22) .
RNA and cDNA preparation
RNA was extracted from brain, pituitary, gastrocnemius muscle, or C2C12 cells using Tri-Reagent RNA isolation reagent (Molecular Research Center, Cincinnati, OH) according to the manufacturer's recommendations. To avoid false-positive results caused by DNA contamination, a deoxyribonuclease treatment was performed for 30 min at 37 C using the RQ1 RNasefree deoxyribonuclease (Promega Corp., Madison, WI). RNA preparations were reverse transcribed to generate cDNA using High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Inc., Foster city, CA). The cDNA products were used as templates for semiquantitative and quantitative PCR analysis.
Semiquantitative RT-PCR
Semiquantitative RT-PCR was used to amplify the levels of endogenous mCRFR2 and mCRFR1 present in the mouse SM and brain. The expression of mCRFR1, mCRFR2 as well as muscle differentiation markers MyoD, myogenin and Id2 levels were studied during C2C12 differentiation. The cDNA products were used as templates for semiquantitative RT-PCR analysis using specific primers for mCRFR2, mCRFR1, MyoD, myogenin, and Id2 and the ribosomal protein S16 (for sequences see Table 1 ).
TABLE 1. Sequence of PCR primers
Gene
Primer sequence (5 to 3) GenBank accession no. CRFR1 NM_007762 Sense GGT GTG CCT TTC CCC ATC ATT Antisense CAA CAT GTA GGT GAT GCC CAG CRFR2 NM_009953 Sense GGC AAG GAA GT GGT GAT TTG Antisense GGC GTG GTG GTC CTG CCA GCG MyoD1 NM_010866 Sense GAG CAA AGT GAA TGA GGC CTT Antisense CAC TGT AGT AGG CGG TGT CGT Myogenin NM_031189 Sense TCA GAA GAG GAT GCT CTC TGC Antisense TCA GAA GAG GAT GCT CTC TGC Id2 NM_010496 Sense ATG AAA GCC TTC AGT CCG GTG Antisense TTA GCC ACA GAG TAC TTT GCT S16 M11408 Sense TGC GGT GTG GAG CTC GTG CTT GT Antisense GCT ACC AGG CCT TTG AGA TGG A PCR without reverse transcriptase enzyme (ϪR.T) or without cDNA (ϪcDNA) served as negative control. The expression of ribosomal protein S16 served as internal control. The PCR conditions were as follows: cDNA equivalent to 200 ng of total RNA was amplified by PCR for 35 cycles at an annealing temperature of 62 C. The final MgCl 2 concentration was 3 mM, and each reaction contained 2.5 U of Taq DNA polymerase (BIO-X-ACT DNA polymerase; Bioline UK Ltd., London, UK).
RNase protection assay
SM total RNA was hybridized with the mCRFR1, mCRFR2, and glyceraldehyde-3-phosphate dehydrogenase antisense probes. Brain and pituitary gland served as positive control for CRFR2 and CRFR1 gene expression, respectively. RNase protection assay was performed as previously described (23) .
Transient transfections and luciferase assay
C2C12 were used for the CRE activation and for the promoter studies. All transfections were carried out in 12-well plates using Lipofectamine 2000 Transfection Reagent (Invitrogen Life Technologies) according to manufacturer's instructions. For CRE-luciferase activation, C2C12 myoblasts were plated to 90% confluency and transfected with 1.5 g of the luciferase reporter containing a fragment of the EVX1 gene, which contains a potent CRE site (kindly provided by Marc Montminy, The Salk Institute) and 50 ng ␤-gal expression plasmid. Cells were treated for 4 h with vehicle or 1 pM, 0.1 nM, 10 nM, and 1 M CRF or Ucn3 in nondifferentiated C2C12 cells, or 48 h differentiated C2C12 cells with or without the presence of CRFR1-and CRFR2-selective antagonists (Ant and Ast 2B, respectively). For promoter studies, C2C12 myoblasts were plated to 90% confluency and transfected with 1.5 g of the luciferase reporter plasmid or empty pGL3 vector and 50 ng ␤-gal expression plasmid. After 24 h the medium was replaced with DM. The promoter activity was monitored at the basal state and after the indicated times (24 -96 h) in DM. The cells were harvested, and the luciferase reporter activity was assayed as previously described (20) . Transfections were performed at least three times (in triplicate) for each construct or treatment tested. To correct for variations in transfection efficiencies, luciferase activities were normalized to ␤-gal activity. Results were corrected by the activity of the promoterless pGL3 vector.
Calcium-mobilization assay
Calcium-mobilization kinetics in nondifferentiated or differentiated C2C12 cells or in CHO cells stably transfected with either mCRFR1 or mCRFR2 after treatment of CRF or Ucn2 (50 nM) were measured using FlexStation (Molecular Devices, Sunnyvale, CA) as previously described (67) .
Construction of luciferase reporter plasmids
The mCRFR1 and mCRFR2␤ 5Ј-flanking region constructs were cloned by PCR using mouse genomic DNA. The primers used for the construct were designed to include artificial restriction sites (KpnI and XhoI for mCRFR1; KpnI and NheI for mCRFR2␤). The primer sequences were as follows: for mCRFR1 sense primer (Ϫ2685 to 2663): 5Ј-TTG GGT TAC GTA TGC TGC TCC TT-3Ј and antisense primer (ϩ196 to ϩ217): 5Ј-CCT CGG GCT CGC TCT GTC AGC-3Ј. For mCRFR2␤ sense primer (Ϫ2495 to 2473): 5Ј-GGA AAT GCA GGA AAG CCA AGA CA-3Ј and antisense primer (ϩ4 to ϩ23): 5Ј-CTG CCC GAC CTA CCC ACC AA-3Ј. Fragmentation of the mCRFR2␤ 5Ј-flanking region was done using the above mentioned antisense primer along with six sense primers located at: (Ϫ1649 to Ϫ1630), (Ϫ1028 to Ϫ1009), (Ϫ955 to Ϫ932), (Ϫ747 to Ϫ726), (Ϫ512 to Ϫ492), (Ϫ146 to Ϫ127). The primers sequences are indicated in Fig. 4 ; all primers contained an artificial KpnI restriction site. For mutating the MEF2 recognition site located at Ϫ91 to Ϫ82, the proximal 5Ј-flanking area was amplified using the above-mentioned antisense primer with the following sense primer, which contains an endogenous PstI restriction site: 5Ј-CTGCAGAAGTTGCTGCCCAGAGCCA-GATATCAATAACCTGG-3Ј. The mutation introduces a unique EcoRV restriction site (in italics), which was later used for identifying mutated clones. The PCR products were analyzed by agarose gel electrophoresis and eluted from the gel. After digestion by the appropriate restriction enzymes, the DNA fragments were cloned into the luciferase reporter plasmid pGL3 (Promega Corp.), and the sequences were verified using automated direct DNA sequencing.
HFD
Mice were fed ad libitum a high-fat (60% of calories) (n ϭ 13) or low-fat (10% of calories) (n ϭ 5) diet (D12492 and D12450B, respectively; Research Diets, Inc., New Brunswick, NJ) for 15 wk.
CVS
CVS mice (n ϭ 5) were housed in a temperature-controlled room (22 C Ϯ1) and were subjected to the CVS protocol for a period of 4 wk as previously described (22) .
Real-Time PCR
SM cDNA products were used as templates for real-time PCR analysis. Sense and antisense primers were selected to be located on different exons to avoid false-positive results caused by DNA contamination. The following specific primers were designed using Primer Express software (Applied Biosystems, PerkinElmer, Foster City, CA). For mCRFR2: 5Ј-TACCGAATCGCCCTCATTGT-3Ј and 5Ј-CCACGCGATGTTTCTCAGAAT-3Ј corresponding to nucleotides 479-498 and 640-620, respectively (GenBank accession no. AY445512); for mRBP4: 5Ј-GCTTCCGAGTCAAG-GAGAACTTC-3Ј and 5Ј-TCCACAGAAAACTCAGC-GATGA-3Ј corresponding to nucleotides 479-498 and 640-620, respectively (GenBank accession no. NM_011255). For mouse hypoxanthine guanine phosphoribosyl transferase 1 (HPRT1), which served as an internal control: 5Ј-GCAGTACAGC-CCCAAAATGG-3Ј and 5Ј -GGTCCTTTTCACCAG-CAAGCT-3Ј corresponding to nucleotides 389-411 and 509-488, respectively (GenBank accession no. NM_013556). Real-time PCRs were carried out on a 7500 Real-Time PCR system (Applied Biosystems, Inc.), using fluorescent SYBR Green technology (Abgene; Epsom, Surrey, UK). Reaction protocols had the following format: 15 min at 95 C for enzyme activation, followed by 45 cycles of 15 sec at 94 C and 60 sec at 60 C. The specificity of the amplification products was checked by melting curve analysis. All reactions contained the same amount of cDNA, 10 l Master Mix, and 250 nM primers to a final volume of 20 l.
Microarray preparation and data are described under Gene Expression Omnibus accession number GSE25045. Briefly, total RNA was extracted from adult skeletal muscle obtained from four CRFR2 KO mice and four WT littermates, using Tri-Reagent RNA isolation reagent (Molecular Research Cen-ter, Cincinnati, OH) according to the manufacturer's protocol. The RNA was pooled such that each sample consisted of two muscles from each genotype (a total of four samples). Total RNA (100 g) was further cleaned using Qiagen RNA purification kit (QIAGEN Inc., Valencia, CA), and RNA integrity was verified using gel electrophoresis and 260/280 ratios. cRNA synthesis and hybridization to Affymetrix Murine GenomeU74Av2 array (Affymetrix, Santa Clara, CA) was performed by the UCSD Biological Services Unit. Data was analyzed using Affymetrix Microarray Analysis Suite 5.1.
